RecruitingNot Applicable

Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients

Germany30 participantsStarted 2025-12-01

Plain-language summary

This randomized controlled study evaluates the effects of cold water hydrotherapy in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to an usual care setting without hydrotherapy treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of Post-COVID Syndrome (ICD-10 code: U08.9) * Barthel-Index \>80 * Owning a smartphone to receive digital questionnaires and to use the measurement app for heart rate variability * Written informed consent Exclusion Criteria: * Existing contraindications for Kneipp hydrotherapy like severe cardiovascular diseases (e.g., decompensated heart failure, unstable angina pectoris, acute myocardial infarction), severe venous diseases (e.g., acute deep vein thrombosis of the leg), severe neurological diseases (e.g., uncontrolled epilepsy) * Prior regular practice of Kneipp applications

What they're measuring

Health-related quality of life by Short Form-12 Health Survey (SF-12)

Timeframe: From baseline (Visit 1) to end of 3-week program (3 weeks, Visit 2)

Trial details

NCT IDNCT07110714

SponsorEggensberger OHG

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-01-31

Contact for this trial

Andreas Eggensberger, MSc

+4983629103300 a.eggensberger@eggensberger.de

View on ClinicalTrials.gov More Post COVID-19 Condition trials